Menu Back to Latin-America-Regulatory-Conference

Overview

Conference: March 14-16

Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.

DIA brings you a conference with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.

Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.

*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this Conference.

Live Webinar

Forward-Looking to DIA LARC 2022: Insights from CECEMED and Leveraging Lessons Learned from COVID-19

Thursday, February 10, 2022 | 11:00 – 12:00PM ET
DIA’s Latin America Regulatory Conference (LARC) 2022 virtual Promotional Webinar will provide highlights of the key regulatory concepts and discussions initiatives of theto be discussed at DIA’s LARC 2022 3-day conference occurring held on March 14- to 16, 2022. Gain an insider’s view as to what will be discussed at LARC 2022 with a Sspecial focus will be on Cuba's National Regulatory Authority (NRA), Center for State Control of Medicines, Equipment and Medical Devices (Spanish acronyms CECMED). The Promotional Webinar will touch on lessons learned from the pandemic to achieveing a greater regulatory agility and emergency preparedness in the Latin American region.

Register Today

Who should attend?

Professionals involved in:

  • Academia
  • Clinical Research and Development
  • CROs/Vendors
  • Global Submission/Project Management
  • Government Affairs
  • Medical and Scientific Affairs
  • Policy and Intelligence
  • Quality Assurance and Compliance
  • Regulatory Agencies
  • Regulatory Affairs, Operations, and Strategy
  • Research and Development
  • Strategic Sourcing/Planning

Program Committee

  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality Intelligence, Global Supply
    Pfizer Inc, United States
  • Maria Cristina  Mota Pina, MBA
    Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
    AbbVie, Inc., United States
  • Viktoria  Magyar, LLM
    Viktoria Magyar, LLM student
    USC School of Pharmacy, United States
  • Roberta  Mele Mazza, RPh, RAC
    Roberta Mele Mazza, RPh, RAC Q&RA Manager, División Diagnóstica
    Productos Roche , Argentina
  • Gustavo  Mendes Lima Santos, MPharm
    Gustavo Mendes Lima Santos, MPharm General Manager of Medicines and Biological Products
    ANVISA, Brazil
  • Maria Antonieta  Roman, MSc
    Maria Antonieta Roman, MSc DRA Head GDD
    Novartis, Mexico
  • Leonardo  Semprun, RPh
    Leonardo Semprun, RPh Regulatory Affairs Senior Director
    MSD Panama, Panama
  • Sonia  Viejobueno, LLM
    Sonia Viejobueno, LLM Latin America Lead, Global Regulatory Policy and Intelligence
    The Janssen Pharmaceutical Companies of Johnson & Johnson, Argentina
  • Susan  Zavala Coloma, MS, RPh
    Susan Zavala Coloma, MS, RPh Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
    DIGEMID, Peru
  • Cammilla  Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
    Roche, Brazil
Load More